Roundys, FX Allianc...
Health Care: Drugs
Synta Pharmaceuticals Inc. (SNTA: NASDAQ)
$5.21 -0.17 | -3.16%
02/09/12 - 04:00 PM ET
266.67K / 252.10K
Vol / Avg. Vol:5.38 / 5.38
Open / Prev. Close:5.20 - 5.44
Today's Range:3.02 - 6.27
52 Wk Range:15.20%
Performance YTD:TheStreet Rating:
Portfolios with SNTA
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- Userinsider buying
- Contributor5 Stocks With Big Insider B...
- ContributorCancer Drug Stocks to Trade...
- Userbb
- ContributorBarron's Insider Purchases ...
- UserASCO 2010
- ContributorBarron's Insider Purchases ...
- UserASCO 2009 Nymph's Watch List.
Latest SNTA Headlines from TheStreet
- 5 Stocks With Big Insider Buying 01.12.12 | 01:01 pm
- Insiders Trading GOOG, CBRL, LULU, SNTA, MSM 01.11.12 | 09:01 am
- Synta Stock Gaps Down On Today's Open (SNTA) 01.06.12 | 08:01 am
- ASCO Conference Blog Recap 06.04.11 | 05:06 pm
- ASCO: Traders Love Speculative Cancer Stocks 05.19.11 | 06:05 am
- 5 Stocks With Big Insider Buying 04.21.11 | 01:04 pm
- Insiders Trading CODI, SFD, SNTA, IOSP 04.19.11 | 09:04 am
- Synta Pharmaceuticals Inc. Stock Downgraded (SNTA) 03.30.11 | 06:03 pm
- LSB Financial - Upgrades & Downgrades 03.30.11 | 09:03 am
- Synta Stock Gaps Up On Today's Open (SNTA) 02.28.11 | 10:02 am
Press Releases for SNTA
- Synta To Host Fourth-Quarter And Year-End 2011 Conference Call On February 22, 2012 - Business Wire 02.08.12 | 07:02 am
- Synta Pharmaceuticals Sells Additional 1,050,000 Shares Of Common Stock - Business Wire 02.06.12 | 04:02 pm
- Synta Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference - Business Wire 02.06.12 | 08:02 am
- Synta Announces Publication Of Results Showing Ganetespib Synergizes With Taxanes In Multiple Non-small Cell Lung Cancer Models - Business Wire 01.16.12 | 08:01 am
- Synta Pharmaceuticals And University Of Toronto Researchers Elucidate Elesclomol Mechanism Of Action Using Innovative Yeast-based Technology - Business Wire 01.12.12 | 08:01 am
- Synta Pharmaceuticals Closes Public Offering Of Common Stock - Business Wire 01.11.12 | 04:01 pm
- Synta Pharmaceuticals Prices Public Offering Of Common Stock - Business Wire 01.06.12 | 09:01 am
- Synta Pharmaceuticals Announces Proposed Public Offering Of Common Stock - Business Wire 01.05.12 | 04:01 pm
- Ganetespib Potently Inhibits Multiple Signaling Pathways Active In Breast Cancer - Business Wire 12.12.11 | 08:12 am
- Ganetespib Shows Clinical Activity In HER2+ And Triple Negative Metastatic Breast Cancer - Business Wire 12.08.11 | 07:12 am
Partner Headlines for SNTA
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
- McNicoll Lewis & Vlak Reiterates Buy, $10 Target on Synta Pharmaceuticals - Benzinga 12.09.11 | 09:12 am
- 7 Stocks Trading Below $6 With Heavy Insider Buying - Seeking Alpha 12.08.11 | 09:12 am
- 16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money - Seeking Alpha 09.16.11 | 05:09 pm
- Synta to be Showcased in Congress as One of 13 Innovative Companies Seeking More Competitive American Business Environment - Benzinga 09.08.11 | 04:09 pm
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- Drugs to Watch at ASCO 2011 - Seeking Alpha 06.02.11 | 08:06 am
- 6 Cash Rich Biotech Stocks With Catalysts - Seeking Alpha 04.08.11 | 08:04 am
- Low-Priced Biotech Stocks With Insider Buying - Seeking Alpha 03.18.11 | 06:03 pm
- Synta's Lead Program Gains Momentum - Seeking Alpha 12.05.10 | 09:12 am
